Developing Metrics for (E)valuating Efforts that Promote Diversity, Equity, Inclusion, Belonging, and Anti-racism (DEIBA) at UCSF
Hannah Leslie, Miranda Hill, Tor Neilands, Chadwick Campbell (UCSD), Barbara Green-Ajufo, Judy Tan
The University of California San Francisco (UCSF) has established, applied, and periodically revises standards and metrics by which to assess and evaluate scholarly and clinical efforts for the purpose of advancement and improvement (e.g., number of first- or senior-authored peer-reviewed publications and/or research grants awarded). Conversely, diversity, equity, inclusion, belonging, and anti-racism DEIBA efforts lack empirically valid and reliable metrics to accurately capture the work that learners and postdocs, staff, and faculty do to promote DEIBA in the Department of Medicine (DOM). This lack of reliable metrics undercuts efforts of anti-racism, which inadvertently furthers marginalization of minoritized persons and continuously sustains a system of “minority tax’ where people of color (learners, staff, and faculty), who are negatively impacted by racism, bear the burden of finding a solution to racism.
The development of validated DEIBA metrics, used to evaluate growth and change within individuals over time and across groups of individuals overall, will allow the recognition and documentation of the effort towards DEIBA, thereby illuminating the potential impacts of “minority tax” on productivity among students, staff, and faculty of color at UCSF.
The overall goal of this project is to have individuals enacting the DEIBA efforts and whom DEIBA efforts are intended to support employ the Delphi Method to achieve group consensus and systematically develop and share metrics that accurately capture the type, scope, and extent of work required to promote DEIBA at UCSF.
|
|
Sociodemographic Barriers and Facilitators to Vaccine Uptake in the United States: A Quantitative Scoping Review
Orlando Harris, Parya Saberi
Globally, SARS-CoV-2 has infected over 118.3 million people and resulted in over 2.6 million deaths. The US has recorded over 29.1 million cases and over 531,000 deaths, the largest total recorded of any country. US-based COVID-19 infections have disproportionately affected communities of color, specifically, Black/African Americans and Latinx communities. Additionally, despite the availability of three efficacious vaccines that have received emergency use authorization in the US, communities of color have disproportionate rates of vaccination compared to their white counterparts. The prevailing narrative trumpeted by media, public health officials, and politicians is that African Americans are least likely to trust medicine or science due to historical public health maleficence such as The Tuskegee Study of Untreated Syphilis in the Negro Male (The Tuskegee Study).
This narrative negates contemporary racism, failures of the health care system, and the barriers to health care experienced by Black/African American communities. Thus, many of the entrenched structural barriers that are limiting access to the vaccine in Black/African American communities are not being addressed. Therefore, the goal of our project was to conduct a systematic review of the literature to identify barriers and facilitators to vaccine uptake among communities in the United States. Review findings will be published and shared broadly with stakeholders to help improve vaccination rate disparities experienced by communities of color.
|
|
3Rs: Rethinking the Role of Research Incentives – A Feasibility Study
Barbara Green-Ajufo, Andres Maiorana, Deepalika Chakravarty, John Hamiga, Greg Rebchook
In 2020, the Division of Prevention Science in the School of Medicine at the University of California San Francisco launched its antiracism agenda, which aimed to examine its work through an antiracism lens and ensure that antiracist work practices and policies are identified, supported, and addressed.
In academia, most antiracism thinking and resulting strategies are developed to provide institutions and their researchers with policies and practices that speak to dismantling structural systems that promote racism and racial hierarchies, decentralizing whiteness in the research cycle, academic hiring, mentorship, promotions, and access to research funding. While current antiracism thinking and strategies are a welcome start, there is little to no research being done about ways to inculcate antiracism policies and practices towards an equally important group of stakeholders in human subjects research – the research participants themselves. Research about participants is limited to understanding researchers' views about coercion and undue influence and participants’ attitudes regarding payment and how payment affects individuals' decisions to participate in research as well as preferred payment forms. We sought to address this gap in antiracism thinking and strategies and proposed a rethinking of the role of research incentives. Monetary payment (e.g., a $50 gift card) offered to research participants is a feature of most CAPS research studies. Such payments, while arguably needed by and useful to the participant, leave little, if any, lasting mark on them, their family, or their community.
We conducted an online survey and Zoom interviews with community members who were potential participants of research studies and small discussion groups with researchers to examine the feasibility and acceptability of expanding the structure of research incentives to include non-monetary learning options that help participants achieve educational, employment, or life goals. Study findings are promising and potentially will serve as the basis for a future pilot study to evaluate whether research incentives can serve as an antiracism tool to empower and build community.
TOWNHALL VIDEO. Rethinking the Role of Research Incentives:
Preliminary Findings from the 3R's Study
|
|
Multi-Disciplinarity in HIV Cure Research: The Need for Basic and Strategic Socio-Behavioral Sciences and Partner Protections to Promote Global Ethical Research
|
|
This presentation will discuss recent developments in the socio-behavioral sciences of HIV cure-related research involving analytical treatment interruptions (ATIs). We will review and discuss a theoretical framework for partner protections to promote global ethical research and recent empirical findings aimed at increasing diversity in HIV cure-related research in the United States and sub-Saharan Africa.
Dr. Karine Dubé is a senior socio-behavioral scientist and experienced research program manager who integrates biomedical, social sciences, ethics, and patient engagement around HIV-related research in the United States and South Africa. She has close to 20 years of experience in infectious disease-related work, including the socio-behavioral sciences and ethics of HIV cure-related research, HIV prevention, HIV treatment, Ebola, malaria, and HSV-2.
Tuesday, Aug. 15th, 2023
11:00 am- 12:00 pm PST
|
|
Antiracism. Moving Beyond the Equity Statement. Prevention Research Center (PRC) Week 2023 |
|
The purpose of this session is to provide practical tools for implementing and operationalizing antiracism within PRCs. Greg reviews the status of the overall antiracism efforts at PRCs, discusses specific antiracism practices at PRCs including community engagement, hiring, planning, and conducting research, and develops the next steps for implementing at least one new strategy.
Greg Rebchook is a Professor at the Division of Prevention Science.
|
|
A National Vision for PrEP: Financing, Equity, Advocacy |
|
On July 12, the Center for Medicare and Medicaid Services (CMS) proposed a National Coverage Determination for PrEP using antiretrovirals for persons at high risk of HIV acquisition and additional screenings for HIV and hepatitis B virus for high-risk patients. CMS is seeking comments which are due by August Wednesday, August 23rd. Comments are due by August 23.
TOWNHALL VIDEO. Join national experts to learn current and emerging strategies in the PrEP funding landscape, including PrEP4All, 340B drug pricing, Ready Set PrEP, PrEP Assistance Programs, and more.
|
|
TOWN HALL VIDEO. Effecting Change in Health Care Systems: Transforming Practice and Policy to Improve HIV Outcomes.
|
|
In this talk, Dr. Steward discusses research to promote HIV-related practice transformations in healthcare systems and to understand the drivers or barriers to producing a change in these systems.
Wayne Steward, PhD, MPH is a Professor of Medicine in the Division of Prevention Science and co-director of the CAPS Implementation Science and Health Systems Core (ISHS) Core.
|
|
Are you working to prevent HIV in your community?
We are home to 101 prevention scientists, researchers, and staff who conduct high-impact HIV prevention science. We also provide Technical Assistance in the use of HIV science.
|
|
- Consult with one of our researchers
- Review program materials
- Targeted review of grant proposals and surveys
- Assistance in facilitating research and community partnerships
- Consultations on intervention curricula
- Review assessments and measurement tools
- Evaluation resources
|
|
|
The mission of the Center for AIDS Prevention Studies is to end the HIV epidemic and associated health and social disparities by conducting high-impact HIV prevention science and building capacity among researchers and communities to effectively address HIV. Project #2P30MH062246
|
|
The mission of the UCSF Prevention Research Center is to maintain an interdependent network of community, academic, and public health partners to design and implement prevention research aimed at answering significant and innovative HIV research questions and promoting the wide use of practices proven to promote health for those infected and affected by HIV. Project # U48DP006374
|
|
|
|
|
|
|
